CSIRO Food Futures National Research Flagship and Australian company Stadvis Pty Ltd have signed a worldwide license agreement to commercialise an automated instrument that accurately predicts glycemic index (GI) and resistant starch (RS) in food products. The machine will provide the food industry with an accurate means of testing the functional properties and potential human health benefits of new foods that is much quicker and more cost-effective than the current in vivo (human) method. The GI and RS Analyser is the first of its kind in the world. The prototype works by mimicking the human digestion process and was originally developed to test the properties of new grains being developed by the Flagship.
Researchers in the UK found that changes in glucose concentrations, insulin sensitivity, and insulin secretion can be detected as early as 3 to 6 years before diagnosis of diabetes and hope that the discovery will lead to more accurate risk prediction as part of regular check ups. The study was led by a team at University College London and was published in the 8 June early online issue of The Lancet. It was also presented at the 69th Scientific Sessions of the American Diabetes Association that took place in New Orleans, Louisiana earlier this week. Although we know quite a lot about glucose metabolism and insulin, the hormone that helps us use glucose for energy and goes awry in diabetes, we don't know very much about the timing of the changes that lead up to diabetes, wrote the researchers.
CentraState Medical Center (Freehold, New Jersey) has purchased two new state-of-the-art Elekta radiation therapy treatment systems, both with Volumetric Modulated Arc Therapy (VMAT). The first site in the world to have both Elekta Axesse and Elekta Infinity, CentraState will offer the most advanced cancer care available to its patients. CentraState Medical Center, a part of the CentraState Healthcare System, currently is treating 45 to 50 patients a day - with fluctuations as high as 70 patients per day, all on one treatment unit. When the time came to add another treatment system, CentraState elected to replace another manufacturer's system and install two new Elekta systems.
Bioheart To Introduce Improved Heart Failure Monitoring Systems At Heart Failure Nurses Annual Meeting
Bioheart, Inc., (OTC Bulletin Board: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases announced that the company will be introducing its heart failure monitoring systems at the American Association of Heart Failure Nurses 5th Annual Meeting. This year's meeting will take place from June 25 - 27, 2009 at the Hyatt Regency Minneapolis in Minneapolis, Minnesota. The compact Bioheart 3370 home heart failure monitor engages patients through personalized daily interactions and questions, while collecting vital signs and transmitting the information directly into a database.
A study in the New England Journal of Medicine has found common surgical interventions and stents, the expensive medical devices used in bypass surgeries, are no more effective at preventing death, heart attacks and strokes in diabetic patients than less expensive drugs, the Wall Street Journal reports. The study, which included 2, 368 patients, is representative of new interest in head-to-head comparisons of treatments. "Funding for similar 'comparative effective' studies have just been given a big boost. These bake-offs between competing therapies for the same condition have been hailed as a possible answer to wasteful health-care spending in the U.
Toshiba America Medical Systems Selected By The Premier Healthcare Alliance To Highlight Commitment To Healthcare Quality Improvement, Innovation
Toshiba America Medical Systems, Inc. was recently selected to participate in the Premier healthcare alliance's first Innovation Celebration, an annual event to celebrate advances in healthcare while highlighting healthcare industry suppliers committed to innovation and improving patient outcomes. Premier's Innovation Celebration highlights innovative solutions that bring a positive impact to healthcare delivery. The 26 products showcased were selected by a cross-functional team of Premier alliance members and staff of varying expertise, including clinical product planners, clinical field specialists, pharmacists, supply chain professionals, materials management and nurses.